Societal CDMO Inc

SCTL
1,10
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 02:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/4/202422:05GLOBECoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
08/4/202416:10BWCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
11/3/202422:04EDGAR2Form SC 14D9 - Solicitation, recommendation statements
11/3/202421:05EDGAR2Form SC TO-T - Tender offer statement by Third Party
06/3/202423:11EDGAR2Form SC 13D - General statement of acquisition of beneficial..
29/2/202423:18EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202423:27EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202423:18EDGAR2Form SC14D9C - Written communication relating to third party..
28/2/202422:58EDGAR2Form 8-K - Current report
28/2/202422:29GLOBESocietal CDMO Enters Into Definitive Agreement to be..
01/2/202413:00GLOBESocietal CDMO and Benuvia Sign Co-Marketing Agreement..
05/1/202422:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
28/11/202322:14EDGAR2Form 8-K - Current report
08/11/202322:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:11EDGAR2Form 8-K - Current report
08/11/202322:05GLOBESocietal CDMO Reports Third Quarter 2023 Financial Results
01/11/202321:05GLOBESocietal CDMO to Report Financial Results for Third Quarter..
05/10/202322:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
25/9/202322:05GLOBESocietal CDMO to Participate in RBC Capital Markets Virtual..
20/9/202322:10EDGAR2Form 8-K - Current report
20/9/202322:05GLOBESocietal CDMO Announces Corporate Restructuring
07/9/202313:00GLOBESocietal CDMO Secures Project Expansion Agreements With..
29/8/202313:00GLOBESocietal CDMO Announces Closing of $8.3 Million Public..
28/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202322:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/8/202322:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
24/8/202313:30GLOBESocietal CDMO Announces Pricing of $8.3 Million Public..
23/8/202322:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202322:13EDGAR2Form 8-K - Current report
23/8/202322:04GLOBESocietal CDMO Announces Appointment of Matt Arens to Board..
23/8/202322:04GLOBESocietal CDMO Announces Proposed Public Offering of Common..
14/8/202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:28EDGAR2Form 8-K - Current report
14/8/202322:05GLOBESocietal CDMO Reports Second Quarter 2023 Financial Results
09/8/202313:00GLOBESocietal CDMO Reschedules Second Quarter 2023 Financial..
07/8/202321:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/8/202322:05GLOBESocietal CDMO to Report Financial Results for Second Quarter..
26/7/202313:00GLOBESocietal CDMO Announces Expansion of Controlled Substance..
10/7/202313:00GLOBESocietal CDMO Selected by Spinnaker Biosciences to Provide..
07/7/202322:05GLOBESocietal CDMO Reports Inducement Grants for New Staff
29/6/202313:00GLOBESocietal CDMO Signs Master Service Agreement With..
23/5/202313:00GLOBESocietal CDMO Enters Agreement With Atossa Therapeutics to..
10/5/202322:05GLOBESocietal CDMO Reports First Quarter 2023 Financial Results
09/5/202322:05GLOBESocietal CDMO to Participate in RBC Capital Markets Global..
08/5/202313:00GLOBESocietal CDMO Selected by Xequel Bio to Provide CDMO..
Apertura: Min: Max:
Chiusura: 1,10

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network